Stanley K. Lau - 31 Mar 2024 Form 4 Insider Report for Cardio Diagnostics Holdings, Inc. (CDIO)

Role
Director
Signature
/s/ Elisa Luqman as attorney-in-fact for Stanley Lau
Issuer symbol
CDIO
Transactions as of
31 Mar 2024
Net transactions value
+$25,000
Form type
4
Filing time
08 Apr 2024, 15:22:20 UTC
Previous filing
05 Feb 2024
Next filing
02 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDIO Common Stock Options Exercise $12,500 +8,803 +9.6% $1.42 100,325 31 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDIO Restricted Stock Units Options Exercise $12,500 $37,400 31 Mar 2024 Common Stock $12,500 $0.000000 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the settlement of restricted stock units (RSUs) that vested on March 31, 2024 through the issuance of shares of Common Stock.
F2 Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.
F3 Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.
F4 The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.